These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 660684

  • 1. Resistant Enterobacter cloacae in a burn center: the ineffectiveness of silver sulfadiazine.
    Gayle WE, Mayhall CG, Lamb VA, Apollo E, Haynes BW.
    J Trauma; 1978 May; 18(5):317-23. PubMed ID: 660684
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Properties of silver sulfadiazine-resistant Enterobacter cloacae.
    Rosenkranz HS, Coward JE, Wlodkowski TJ, Carr HS.
    Antimicrob Agents Chemother; 1974 Feb; 5(2):199-201. PubMed ID: 4840432
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
    Hoffmann S.
    Scand J Plast Reconstr Surg; 1984 Feb; 18(1):119-26. PubMed ID: 6377481
    [Abstract] [Full Text] [Related]

  • 9. Comparison of 1% silver sulfadiazine with and without 1% chlorhexidine digluconate for topical antibacterial effect in the burnt infected rat.
    Snelling CF, Roberts FJ.
    J Burn Care Rehabil; 1988 Feb; 9(1):35-40. PubMed ID: 3128553
    [Abstract] [Full Text] [Related]

  • 10. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival.
    Salisbury RE, Bevin AG, Steinkraus GE, Enterline DS.
    J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Enterobacter cloacae septicemia in a burn center: epidemiology and control of an outbreak.
    Mayhall CG, Lamb VA, Gayle WE, Haynes BW.
    J Infect Dis; 1979 Feb; 139(2):166-71. PubMed ID: 438531
    [Abstract] [Full Text] [Related]

  • 13. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing.
    Robb EC, Nathan P.
    J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An experimental evaluation of the germicidal efficacy of three topical antimicrobial agents in burns.
    Rode H, de Wet PM, Davies MR, Cywes S.
    Prog Pediatr Surg; 1981 Oct; 14():189-208. PubMed ID: 7221007
    [Abstract] [Full Text] [Related]

  • 16. Clinical comparison of maphenide and silver sulphadiazine.
    Pegg SP, Ramsay K, Meldrum L, Laundy M.
    Scand J Plast Reconstr Surg; 1979 Oct; 13(1):95-101. PubMed ID: 451487
    [Abstract] [Full Text] [Related]

  • 17. Silver sulfadiazine (AgSD) resistant pseudomonas infection in experimental burn wounds.
    Modak SM, Stanford JW, Bradshaw W, Fox CL.
    Panminerva Med; 1983 Oct; 25(3):181-8. PubMed ID: 6669393
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.